Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Clinical Research Centre, Lund University, Lund, Sweden.
Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Diabetologia. 2023 Feb;66(2):321-335. doi: 10.1007/s00125-022-05811-5. Epub 2022 Oct 12.
AIMS/HYPOTHESIS: Excess adiposity is differentially associated with increased risk of cardiometabolic disease in men and women, according to observational studies. Causal inference studies largely assume a linear relationship between BMI and cardiometabolic outcomes, which may not be the case. In this study, we investigated the shapes of the causal relationships between BMI and cardiometabolic diseases and risk factors. We further investigated sex differences within the causal framework.
To assess causal relationships between BMI and the outcomes, we used two-stage least-squares Mendelian randomisation (MR), with a polygenic risk score for BMI as the instrumental variable. To elucidate the shapes of the causal relationships, we used a non-linear MR fractional polynomial method, and used piecewise MR to investigate threshold relationships and confirm the shapes.
BMI was associated with type 2 diabetes (OR 3.10; 95% CI 2.73, 3.53), hypertension (OR 1.53; 95% CI 1.44, 1.62) and coronary artery disease (OR 1.20; 95% CI 1.08, 1.33), but not chronic kidney disease (OR 1.08; 95% CI 0.67, 1.72) or stroke (OR 1.08; 95% CI 0.92, 1.28). The data suggest that these relationships are non-linear. For cardiometabolic risk factors, BMI was positively associated with glucose, HbA, triacylglycerol levels and both systolic and diastolic BP. BMI had an inverse causal relationship with total cholesterol, LDL-cholesterol and HDL-cholesterol. The data suggest a non-linear causal relationship between BMI and BP and other biomarkers (p<0.001) except lipoprotein A. The piecewise MR results were consistent with the fractional polynomial results. The causal effect of BMI on coronary artery disease, total cholesterol and LDL-cholesterol was different in men and women, but this sex difference was only significant for LDL-cholesterol after controlling for multiple testing (p<0.001). Further, the causal effect of BMI on coronary artery disease varied by menopause status in women.
CONCLUSIONS/INTERPRETATION: We describe the shapes of causal effects of BMI on cardiometabolic diseases and risk factors, and report sex differences in the causal effects of BMI on LDL-cholesterol. We found evidence of non-linearity in the causal effect of BMI on diseases and risk factor biomarkers. Reducing excess adiposity is highly beneficial for health, but there is greater need to consider biological sex in the management of adiposity.
目的/假设:根据观察性研究,过多的体脂与男性和女性患心血管代谢疾病的风险增加有关。因果推理研究主要假设 BMI 与心血管代谢结果之间存在线性关系,但事实可能并非如此。在这项研究中,我们研究了 BMI 与心血管代谢疾病和危险因素之间因果关系的形状。我们还在因果框架内研究了性别差异。
为了评估 BMI 与结果之间的因果关系,我们使用两阶段最小二乘法孟德尔随机化(MR),将 BMI 的多基因风险评分作为工具变量。为了阐明因果关系的形状,我们使用了非线性 MR 分数多项式方法,并使用分段 MR 来研究阈值关系并确认形状。
BMI 与 2 型糖尿病(OR 3.10;95%CI 2.73,3.53)、高血压(OR 1.53;95%CI 1.44,1.62)和冠心病(OR 1.20;95%CI 1.08,1.33)相关,但与慢性肾病(OR 1.08;95%CI 0.67,1.72)或中风(OR 1.08;95%CI 0.92,1.28)无关。数据表明这些关系是非线性的。对于心血管代谢危险因素,BMI 与葡萄糖、HbA、三酰甘油水平以及收缩压和舒张压均呈正相关。BMI 与总胆固醇、LDL-胆固醇和 HDL-胆固醇呈负相关。数据表明 BMI 与血压和其他生物标志物(p<0.001)之间存在非线性因果关系(除脂蛋白 A 外)。分段 MR 结果与分数多项式结果一致。BMI 对冠心病、总胆固醇和 LDL-胆固醇的因果效应在男性和女性中不同,但在控制多重检验后(p<0.001),这种性别差异仅在 LDL-胆固醇中显著。此外,BMI 对女性冠心病的因果效应因绝经状态而异。
结论/解释:我们描述了 BMI 对心血管代谢疾病和危险因素的因果效应的形状,并报告了 BMI 对 LDL-胆固醇的因果效应的性别差异。我们发现 BMI 对疾病和危险因素生物标志物的因果效应存在非线性。减少过多的体脂对健康非常有益,但在管理肥胖症时更需要考虑生物学性别。